The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca 2+ signalling in steatotic hepatocytes

Abstract

The release of Ca(2+) from the endoplasmic reticulum (ER) and subsequent replenishment of ER Ca(2+) by Ca(2+) entry through store-operated Ca(2+) channels (SOCE) play critical roles in the regulation of liver metabolism by adrenaline, glucagon and other hormones. Both ER Ca(2+) release and Ca(2+) entry are severely inhibited in steatotic hepatocytes. Exendin-4, a slowly-metabolised glucagon-like peptide-1 (GLP-1) analogue, is known to reduce liver glucose output and liver lipid, but the mechanisms involved are not well understood. The aim of this study was to determine whether exendin-4 alters intracellular Ca(2+) homeostasis in steatotic hepatocytes, and to evaluate the mechanisms involved. Exendin-4 completely reversed lipid-induced inhibition of SOCE in steatotic liver cells, but did not reverse lipid-induced inhibition of ER Ca(2+) release. The action of exendin-4 on Ca(2+) entry was rapid in onset and was mimicked by GLP-1 or dibutyryl cyclic AMP. In steatotic liver cells, exendin-4 caused a rapid decrease in lipid (half time 6.5min), inhibited the accumulation of lipid in liver cells incubated in the presence of palmitate plus the SOCE inhibitor BTP-2, and enhanced the formation of cyclic AMP. Hormone-stimulated accumulation of extracellular glucose in glycogen replete steatotic liver cells was inhibited compared to that in non-steatotic cells, and this effect of lipid was reversed by exendin-4. It is concluded that, in steatotic hepatocytes, exendin-4 reverses the lipid-induced inhibition of SOCE leading to restoration of hormone-regulated cytoplasmic Ca(2+) signalling. The mechanism may involve GLP-1 receptors, cyclic AMP, lipolysis, decreased diacylglycerol and decreased activity of protein kinase C.

The Role of Neuropeptide Y in Cardiovascular Health and Disease

“…Molecularly, Y1R, Y2R, and Y5R are coupled to a G α i subunit and have been shown to hinder the synthesis of cyclic adenosine monophosphate (cAMP) via adenylyl cyclase inhibition (Kassis et al, 1987 ; Motulsky and Michel, 1988 ; Ali et al, 2016 ), reducing protein kinase A (PKA) dependent stimulation of the L-type calcium (Ca 2+ ) current (Bryant and Hart, 1996 ; Larhammar, 1996 ; Lee et al, 2003 ; Gehlert, 2004 ; Troke et al, 2013 ). There may also be direct G protein coupling to inhibit N-type Ca 2+ channels (Hirning et al, 1990 ; Wiley et al, 1990 ) and stimulate inwardly rectifying potassium (K + ) channels (GIRK) (Sun et al, 2001 ; Acuna-Goycolea et al, 2005 ).…”

Molecular Identification, Characterization, and Expression Analysis of a Gonadotropin-Releasing Hormone Receptor (GnRH-R) in Pacific Abalone, Haliotis discus hannai

“…The presence of four cysteine residues that are likely to form disulfide bridges suggest that they are crucial for the packing and stabilizing of a restricted number of conformations of these seven transmembrane helical segments [ 27 ]. The phosphorylation site of the cloned receptor plays a key role for several signal transduction cascades [ 28 ]. The identified Cys-459 residues in C-terminal tail of this receptor serve as a potential site for palmitoylation.…”

Exploring genetic susceptibility to obesity through genome functional pathway analysis

“…The top scoring genes in terms of key pathway involvement included cytokines and growth factors implicated in tumorigenesis (Table ), particularly CREB1, IGF1, INS , and IL6 . These four genes are all involved in the cAMP‐dependent protein kinase pathway, instrumental in intracellular signal transduction and mediating glycogen, sugar, and lipid metabolism .…”